Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results. (Q55038929)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results. |
scientific article |
Statements
1 reference
Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results. (English)
1 reference
John P Leonard
1 reference
Morton Coleman
1 reference
Jamie C Ketas
1 reference
Amy Chadburn
1 reference
Richard Furman
1 reference
Michael W Schuster
1 reference
Eric J Feldman
1 reference
Michelle Ashe
1 reference
Stephen J Schuster
1 reference
William A Wegener
1 reference
Hans J Hansen
1 reference
Heather Ziccardi
1 reference
Michael Eschenberg
1 reference
Urte Gayko
1 reference
Scott Z Fields
1 reference
Alessandra Cesano
1 reference
David M Goldenberg
1 reference
1 August 2004
1 reference
10
1 reference
16
1 reference
5327-5334
1 reference
Identifiers
1 reference